GE Healthcare announces first patient dosed in phase-III clinical trial for new dopamine transporter imaging radiopharma Read more
US FDA grants Breakthrough Therapy Designation to Pfizer’s Respiratory Syncytial Virus vaccine candidate Read more
Evotec receives €3 million payment for Bayer starting phase-II clinical development of DNP programme Read more
Astellas’ fezolinetant fails to meet pre-defined endpoints for efficacy in Moonlight clinical trial Read more